Market cap of ADiTx Therapeutics Inc. [ADTX] reaches 68.49M – now what?

ADiTx Therapeutics Inc. [NASDAQ: ADTX] jumped around 1.16 points on Thursday, while shares priced at $5.26 at the close of the session, up 28.29%. The company report on January 29, 2021 that Immunologist and Clinical Transplant Expert, Dolly B. Tyan, PhD, Joins Aditxt as Senior VP of Clinical Development – Transplantation.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Dr. Tyan Will Lead and Advance Organ Transplantation Therapeutic Program.

via NewMediaWire– Aditx Therapeutics, Inc. (Aditxt) (Nasdaq: ADTX), a biotech innovation company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, announced the appointment of Dr. Dolly B. Tyan as Senior Vice President of Clinical Development – Transplantation. In this role, Dr. Tyan will be overseeing Aditxt’s therapeutic program for organ rejection including advancing current candidates towards clinical trials and developing new products for new applications.

ADiTx Therapeutics Inc. stock is now 152.88% up from its year-to-date (YTD) trading value. ADTX Stock saw the intraday high of $5.59 and lowest of $4.17 per share. The company’s 52-week high price is 9.58, which means current price is +156.59% above from all time high which was touched on 01/21/21.

Compared to the average trading volume of 3.75M shares, ADTX reached a trading volume of 16956008 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about ADiTx Therapeutics Inc. [ADTX]?

The Average True Range (ATR) for ADiTx Therapeutics Inc. is set at 0.53 The Price to Book ratio for the last quarter was 2.84, with the Price to Cash per share for the same quarter was set at 1.05.

How has ADTX stock performed recently?

ADiTx Therapeutics Inc. [ADTX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 44.11. With this latest performance, ADTX shares gained by 124.79% in over the last four-week period, additionally plugging by 12.15% over the last 6 months.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ADTX stock in for the last two-week period is set at 77.54, with the RSI for the last a single of trading hit 81.53, and the three-weeks RSI is set at 74.83 for ADiTx Therapeutics Inc. [ADTX]. The present Moving Average for the last 50 days of trading for this stock 2.64, while it was recorded at 4.02 for the last single week of trading.

ADiTx Therapeutics Inc. [ADTX]: Deeper insight into the fundamentals

Reflecting on the efficiency of the workforce at the company, ADiTx Therapeutics Inc. [ADTX] managed to generate an average of -$2,913,864 per employee.ADiTx Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 18.90 and a Current Ratio set at 18.90.

Insider trade positions for ADiTx Therapeutics Inc. [ADTX]

There are presently around $1 million, or 6.80% of ADTX stock, in the hands of institutional investors. The top three institutional holders of ADTX stocks are: SABBY MANAGEMENT, LLC with ownership of 224,971, which is approximately New of the company’s market cap and around 25.02% of the total institutional ownership; WEDBUSH SECURITIES INC, holding 61,832 shares of the stock with an approximate value of $0.25 million in ADTX stocks shares; and BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, currently with $62000.0 in ADTX stock with ownership of nearly 0% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in ADiTx Therapeutics Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 7 institutional holders increased their position in ADiTx Therapeutics Inc. [NASDAQ:ADTX] by around 317,674 shares. Additionally, 3 investors decreased positions by around 147,974 shares, while 2 investors held positions by with 131,227 shares. The mentioned changes placed institutional holdings at 334,421 shares, according to the latest SEC report filing. ADTX stock had 6 new institutional investments in for a total of 317,639 shares, while 3 institutional investors sold positions of 147,974 shares during the same period.

Share on facebook
Share on twitter
Share on linkedin
Share on skype
Share on reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam